Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

US Patent 8859207 · Granted Oct 14, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small molecule inhibitors of lactate dehydrogenase and methods of use thereof2025
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2025
Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of l2025
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof2024
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2024
Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of l2023
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof2022
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof2021
1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of2021
Nuclear receptor modulators and their use for the treatment and prevention of ca2020
Nuclear receptor modulators and their use for the treatment and prevention of ca2020
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2020